Praveen Tipirneni, MD is CEO and President of Morphic Therapeutic Inc. He previously worked as Senior Vice President of Global Strategy and Corporate Development at Cubist Pharmaceuticals until the company's acquisition in 2015. He has an MBA in Healthcare Finance from Wharton Business School.
Praveen Tipirneni
